Reunion Neuroscience Price Prediction

REUNDelisted Stock  USD 1.12  0.01  0.90%   
The value of RSI of Reunion Neuroscience's the stock price is about 65 indicating that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Reunion, making its price go up or down.

Oversold Vs Overbought

65

 
Oversold
 
Overbought
The successful prediction of Reunion Neuroscience's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Reunion Neuroscience, which may create opportunities for some arbitrage if properly timed.
Using Reunion Neuroscience hype-based prediction, you can estimate the value of Reunion Neuroscience from the perspective of Reunion Neuroscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Reunion Neuroscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Reunion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Reunion Neuroscience after-hype prediction price

    
  USD 1.12  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reunion Neuroscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.860.861.23
Details
Naive
Forecast
LowNextHigh
1.231.231.23
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.111.121.13
Details

Reunion Neuroscience After-Hype Price Prediction Density Analysis

As far as predicting the price of Reunion Neuroscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Reunion Neuroscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Reunion Neuroscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Reunion Neuroscience Estimiated After-Hype Price Volatility

In the context of predicting Reunion Neuroscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Reunion Neuroscience's historical news coverage. Reunion Neuroscience's after-hype downside and upside margins for the prediction period are 1.12 and 1.12, respectively. We have considered Reunion Neuroscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.12
1.12
After-hype Price
1.12
Upside
Reunion Neuroscience is very steady at this time. Analysis and calculation of next after-hype price of Reunion Neuroscience is based on 3 months time horizon.

Reunion Neuroscience Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Reunion Neuroscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Reunion Neuroscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Reunion Neuroscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
8 Events / Month
5 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.12
1.12
0.00 
0.00  
Notes

Reunion Neuroscience Hype Timeline

Reunion Neuroscience is at this time traded for 1.12. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Reunion is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Reunion Neuroscience is about 0.0%, with the expected price after the next announcement by competition of 1.12. About 34.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Reunion Neuroscience recorded a loss per share of 2.51. The entity last dividend was issued on the 6th of October 2020. The firm had 1:5 split on the 17th of August 2022. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Reunion Neuroscience Related Hype Analysis

Having access to credible news sources related to Reunion Neuroscience's direct competition is more important than ever and may enhance your ability to predict Reunion Neuroscience's future price movements. Getting to know how Reunion Neuroscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Reunion Neuroscience may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BRAXFBraxia Scientific Corp 0.00 0 per month 12.10  0.11  50.00 (33.33) 133.33 
ONTTFOxford Nanopore Technologies 0.00 0 per month 4.04  0.02  11.11 (7.58) 21.94 
AGNPFAlgernon Pharmaceuticals 0.00 0 per month 0.00 (0.02) 16.58 (15.66) 55.53 
AWKNFAwakn Life Sciences 0.00 0 per month 11.34  0.04  19.14 (23.93) 93.51 
ACUTAccustem Sciences 0.11 8 per month 7.84  0.03  20.00 (20.37) 52.38 
NUVLNuvalent 0.63 10 per month 2.69  0.03  3.84 (4.61) 36.85 
OKYOOKYO Pharma Ltd 0.01 3 per month 4.07  0.01  14.55 (8.65) 32.59 
OCTHFOxford Cannabinoid Technologies 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NTIINeurobiological Technologies 0.00 3 per month 0.00  0.00  0.00  0.00  0.00 
PHGUFPharming Group NV 0.00 0 per month 0.00 (0.11) 0.00  0.00  21.69 
HESGHealth Sciences Gr 0.00 1 per month 0.00  0.00  0.00  0.00  0.00 
MMIRFMedMira 0.00 0 per month 0.00  0.12  0.00 (0.17) 321.49 
SABSWSAB Biotherapeutics(0.03)1 per month 11.04  0.21  52.09 (24.13) 102.82 
SNTISenti Biosciences(0.03)2 per month 0.00 (0.1) 7.04 (7.36) 29.17 
CINGCingulate 0.26 5 per month 0.00 (0.12) 9.27 (10.28) 38.00 
BLCMBellicum Pharmaceuticals 0.42 13 per month 14.01  0.04  23.53 (20.00) 191.61 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 

Reunion Neuroscience Additional Predictive Modules

Most predictive techniques to examine Reunion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Reunion using various technical indicators. When you analyze Reunion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Reunion Neuroscience Predictive Indicators

The successful prediction of Reunion Neuroscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Reunion Neuroscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Reunion Neuroscience based on analysis of Reunion Neuroscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Reunion Neuroscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Reunion Neuroscience's related companies.

Story Coverage note for Reunion Neuroscience

The number of cover stories for Reunion Neuroscience depends on current market conditions and Reunion Neuroscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Reunion Neuroscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Reunion Neuroscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Reunion Neuroscience Short Properties

Reunion Neuroscience's future price predictability will typically decrease when Reunion Neuroscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Reunion Neuroscience often depends not only on the future outlook of the potential Reunion Neuroscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Reunion Neuroscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding11.7 M
Cash And Short Term Investments27.2 M
Shares Float2.8 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Reunion Stock

If you are still planning to invest in Reunion Neuroscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reunion Neuroscience's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios